Thanks for posting this. This aligns exactly with Amarins bull thesis and why I continue to think amarin will not partner or sale until the reduce trial results are known.
"study showed that the accuracy of the serum EPA level for predicting NCPs was almost equal to that of the EPA/AA ratio"
This is really important. In our society, the n-6s are so high in our diet it takes a lot of EPA to move the AA/EPA dial...The fact that the absolute amount of EPA in the serum is almost equally important as the AA/EPA is great news for Vascepa..